Who owns YS BIOPHARMA CO LTD?
- Ticker: YS
- CUSIP Number: g9845f109
Tip: Access positions for across all investors
Analyze quarterly positions in Ys Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ys Biopharma stock
Who bought or sold YS BIOPHARMA CO LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 1.5M | $1.1M | -53% | Mar 2024 |
|
| Fil | 1.2M | $843k | -55% | Mar 2024 |
|
| FMR | 1.2M | $816k | 0% | Mar 2024 |
|
| Hillhouse Capital Advisors | 752k | $405k | 0% | Dec 2023 |
|
| Bank Of Montreal | 344k | $275k | 100% | Mar 2024 |
|
| Superstring Capital Management | 308k | $216k | 0% | Mar 2024 |
|
| Pinpoint Asset Management | 50k | $3.6k | 0% | Mar 2024 |
|
| Geode Capital Management | 14k | $9.5k | 0% | Mar 2024 |
|
| Wolverine Asset Management | 499.00 | $358.980600 | 0% | Mar 2024 |
|
Who sold out of Ys Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Valliance Asset Management | Dec 2023 | 1.6M | $821k |
| Snow Lake Management | Sep 2023 | 357k | $286k |
| Citadel Advisors | Dec 2023 | 43k | $23k |